J Sainsbury (SBRY) raised its dividend and reports higher earnings for the first half of the year. The London-based food retailer says revenue excluding VAT and including fuel for the 28 weeks to September 13 rises 2.8% to GBP17.58 billion from GBP17.11 billion a year prior. Pretax profit rises 5.0% to GBP271 million from GBP258 million, while underlying pretax profit jumps 10% to GBP340 million from GBP309 million. Basic earnings per share more than double to 7.2 pence from 3.2p. J Sainsbury raises its interim dividend per share to 4.1p from 3.9p a year prior. (Alliance News)
Comment: Given how many new and hungry people are coming to the UK every day, one would have thought that SBRY on this basis along would be a winner, along with the rest of the supermarkets. Today’s announcement underlines this.
Allergy Therapeutics (AGY), the fully integrated commercial biotechnology company specialising in allergy immunotherapies, announces that it is exploring a dual primary listing of its ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited (“HKEX”). This potential listing in Hong Kong, alongside the Company’s existing listing on the London Stock Exchange’s AIM market, reflects Allergy Therapeutics’ desire to expand its presence in Asia and become a global leader in allergy treatments, while also enhancing trading liquidity in its ordinary shares.
Comment: It is surprising to know that given AIM is such a world beating, wonderful, cheap, non-over-regulated market, awash with liquidity, and friendly, help non expensive Nomads, that a company would actually consider having a dual listing somewhere else.
Pulsar Helium Inc. (PLSR), a helium exploration and development company, announced that on November 5, 2025, all of the 15,500,000 share purchase warrants held by its major shareholder ABCrescent Cooperatief U.A., have been exercised at an exercise price of CAD$0.36, and generated cash proceeds for the Company of CAD$5,580,000. The funds strengthen Pulsar’s balance sheet and will be used to advance the Company’s flagship Topaz helium project in Minnesota, USA.
Comment: It is surprising that warrants have such a dirty name in the market “the company is awash with warrants”, when as we see with PLSR, it is money in the back for companies, with the warrant holders fully aligned in terms of wanting to see the share price go as high as possible.
Molten Ventures (GROW), a leading venture capital firm investing in and developing high-growth digital technology businesses, announced a further partial realisation of its holding in Revolut. At 31 March 2025 our fair value holding in Revolut was £157 million. As part of our ongoing portfolio management, we were able to realise c.£25 million in August 2025 and have now realised a further c.£23 million. Our remaining holding in Revolut will be c.£130 million based on the anticipated 30 September 2025 valuation. Cash realisation proceeds for the current financial year to date are now c.£85 million, representing more than 6% of the opening Gross Portfolio Value for FY26, progressing in line with the internal annual target of 10% through the cycle.
Comment: It is interesting that if more than say five people had actually heard of GROW they would actually be really impressed with what the company is doing with Revolut etc. At least the company’s latest news is covered here in the RNS Hotlist.
Tan Delta (TAND), a leading provider of intelligent real time sensor-based monitoring and maintenance systems for commercial and industrial equipment, announced the commencement of a paid for Phase 2 trial by one of the world’s largest multi-national online retailers to evaluate Tan Delta’s real time oil condition analysis and monitoring systems.
Comment: Another company that no one has heard of with decent news that could significantly boost the current market cap of £18m. Given how few companies we now have on the London market, those who are left could perhaps make a bigger splash.
AstraZeneca (AZN) reported higher revenue and profit for the third quarter of the year. Total revenue jumps 12% to USD15.19 billion in the three months to the end of September from USD13.57 billion a year prior. Pretax profit surges 77% to USD3.24 billion from USD1.83 billion, while reported earnings per share rises 77% to USD1.64. The Cambridge, England-based pharmaceutical company says total revenue grew in all major geographic regions. Core EPS rises 14% to USD2.38 in the third quarter. AstraZeneca reiterates its total revenue and core EPS guidance for 2025 at constant exchange rates. AZN said “The strong underlying momentum across our business through the first nine months of the year sets us up well to sustain growth through 2026 and has us on track to deliver our 2030 ambition,” says Chief Executive Officer Pascal Soriot. “Across our pipeline we have announced an unprecedented 16 positive phase three trials this year.” (Alliance News)
Comment: An incredible pipeline is the highlight here at AZN, although even this has been overshadowed by the company moving to move away from the sinking ship that is the UK in terms of a direct listing on the NYSE.
Wise (WISE): Unaudited interim results for the six months ended 30 September 2025. Active customers of 13.4m in the period – an 18% increase on HY FY25 with cross border volume up 24% to £84.9bn, and customer holdings up 37% to £25.3bn as at 30 September 2025. WISE said “Looking ahead, we remain focused on building for the long term: investing in product innovation, infrastructure and partnerships that make moving and managing money even faster, cheaper, easier and more transparent for our customers worldwide.”
Comment: Although WISE is giving the impression that there is no end to the ability of disruptive banks to win, this is now becoming an ever more crowded space, and the topping out of the share price this years hints that the business is starting to get squeezed, if only on margins rather than volume.
Watches of Switzerland Group (WOSG) issued a H1 FY26 Trading Update for the 26 weeks to 26 October 2025 (H1 FY26) Strong H1 FY26 performance driven by US growth. FY26 guidance reiterated. WOSG said: “We have delivered a strong first half, with Group revenue up 10% in constant currency, showing continued momentum across the Group reflecting the strength of our business model, disciplined strategy execution, and improved market trends. The US has been the standout performer, with sales up 20% in constant currency, driven by broad-based growth across brands and categories throughout the period. Investments in our teams, showrooms and digital offer are driving growth, while Roberto Coin is delivering excellent results as we implement our growth acceleration strategy in the first full year of ownership.”
Comment: Apparently there are still plenty of people who have not realised you can tell the time from your phone. In the meantime, the shares continue their post September recovery, and it is noteworthy that the company is strongly focused on rolling out showrooms when one might thing that online would dominate.
Frontier Developments plc (FDEV), a leading developer and publisher of video games based in Cambridge, UK, provided updates on two of its flagship franchises: Jurassic World Evolution and Planet Zoo. FDEV said “We’re thrilled with the player reception to Jurassic World Evolution 3, which has translated into an excellent sales performance. We look forward to sharing a full update on sales across our whole portfolio, including Jurassic World Evolution 3, in January following the festive period. At the same time, we’re delighted to be developing a sequel to Planet Zoo, a game that has been elevated by the incredible creativity and dedication of our community over the past six years.”
Comment: Who needs Pac-Man when you have JWE and Planet Zoo? Apparently with Planet Zoo you meet authentic living animals who think, feel and explore the world you create around them. Presumably, David Attenborough would be impressed. As far as FDEV is concerned, the shares appear deeply entrenched in a strong uptrend and appear set to conquer two year highs near 650p as soon as the end of the year.
Seeing Machines Limited (SEE), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, said it continues to set new standards in automotive safety through its collaboration with Magna, one of the world’s largest Tier 1 Automotive suppliers. Five years ago, Seeing Machines extended its leading Driver Monitoring System (DMS) technology to incorporate a wide field of view and include the monitoring of vehicle occupants for enhanced safety and convenience. This Driver and Occupant Monitoring System (DMS/OMS) solution has matured and today, is delivered via a single camera, including from the rear-view mirror location behind mirror glass, resulting in an overall lower cost vehicle solution for Automotive OEMs.
Comment: People have grown old and died waiting for SEE to get over the line. However, with a bit of AI thrown in it would appear that the company has finally arrived at the promised land. Being in bed with a Tier 1 counterparty speaks for itself.
